Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[What is inflammatory bowel disease?].

Laurent Beaugerie1

  • 1Service de Gastro-Entérologie et Nutrition, Fédération d'Hépato-Gastro-Entérologie, Hôpital Saint-Antoine, 75571 Paris. laurent.beaugerie@sat.aphp.fr

La Revue Du Praticien
|August 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefit-risk balance of advanced therapies in pediatric inflammatory bowel disease: evidence and gaps versus adults.

Inflammatory bowel diseases·2026
Same author

Building a Robust Investigator-Initiated Platform: The I-CARE Experience.

Clinical pharmacology and therapeutics·2026
Same author

Long-term safety of ustekinumab in Crohn's disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease Patients.

United European gastroenterology journal·2025
Same author

Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: The ERIC study.

Alimentary pharmacology & therapeutics·2024
Same author

Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption.

Open forum infectious diseases·2024

Inflammatory bowel diseases (IBD) are chronic intestinal inflammation conditions. Microscopic colitis subtypes, lymphocytic and collagenous colitis, are now recognized as true IBD types.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pathology

Context:

  • Inflammatory bowel diseases (IBD) encompass chronic conditions characterized by intestinal wall inflammation of unknown etiology.
  • Classic IBD types include ulcerative colitis, Crohn's disease, and indeterminate colitis.
  • Microscopic colitis presents distinct pathological features not always aligning with classic IBD classifications.

Purpose:

  • To clarify the classification of microscopic colitis within the spectrum of inflammatory bowel diseases.
  • To establish whether lymphocytic colitis and collagenous colitis meet the diagnostic criteria for IBD.
  • To provide a more inclusive definition of IBD.

Summary:

  • Inflammatory bowel diseases (IBD) are chronic conditions involving intestinal inflammation.

Related Experiment Videos

  • Ulcerative colitis, Crohn's disease, and indeterminate colitis are the main types.
  • Lymphocytic colitis and collagenous colitis, subtypes of microscopic colitis, fulfill IBD criteria and should be classified as true IBD.

    • Impact:

    • This reclassification expands the understanding and diagnostic scope of inflammatory bowel diseases.
    • It ensures patients with lymphocytic and collagenous colitis receive appropriate IBD diagnosis and management.
    • Highlights the importance of considering microscopic colitis in the differential diagnosis of chronic intestinal inflammation.